Webinar recording on derived psychoactive cannabis products
Derived psychoactive cannabis products (DPCPs) have rapidly become available in retail outlets across the U.S. since the 2018 U.S. Agriculture Improvement Act (also known as the Farm Bill) implicitly legalized the product and sale of these products. DPCPs are regulated as “hemp”; there are currently no federal regulations on product safety or marketing. This month, Dr. [More]
Derived psychoactive cannabis products in the retail environment
Derived Psychoactive Cannabis Products (DPCPs) refer to a wide range of products with psychoactive properties similar to cannabis that are chemically created, rather than grown. Despite the public health risks, many states have only recently begun efforts to regulate the sale of the DPCPs that have saturated the market due to gaps in state and [More]
3 lessons from tobacco control that can be used in cannabis regulations
With adult use cannabis now legalized in 18 states and counting, it seems pretty clear that recreational cannabis will soon be available in more retail spaces across the country, whether public health is ready for it or not. As the cannabis industry begins to implement many of the same strategies perfected by the tobacco industry [More]
Lessons from tobacco control for cannabis policy
The majority of Americans live in a state where cannabis is legal and marijuana has been decriminalized, while a growing number of states have legalized recreational marijuana. Here are a few lessons we can learn from past tobacco control challenges and successes to build a more equitable, health-focused cannabis policy landscape. New research from University [More]
